StreetAlpha.app
Home › Stocks › STXS

Stereotaxis, Inc. (STXS)

$0.88
▲ +9.56%
LAST CLOSE · NOV 17

Stereotaxis makes electromedical systems and disposable devices that physicians use in interventional procedures. It last closed at $0.88 on Nov 17, up 9.56% on the day. STXS last reported earnings on Tue, Aug 11, 2026. The average 12-month price target from 2 analysts is $2.50 (+183.4% from the last close), with a high of $3.00 and a low of $2.00.

AI Auto Pilots
Is STXS in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$31.5M
+4.8% vs a year ago
Net income
−$22.3M
−70.9% margin
EPS (diluted)
−$0.24
Free cash flow
−$15.5M
−49.2% margin
Valuation
Market cap
$89.0M
100.9M shares
P/E
–
No P/E while losing money
Price to sales
2.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$4.0M
At Sep 30
Debt
$2.5M
At Sep 30
Shareholder equity
$21.4M
Shares outstanding
100.9M
At Oct 31
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $35.0M$35.0MFY2021FY2022: $28.1M$28.1MFY2022FY2023: $26.8M$26.8MFY2023FY2024: $26.9M$26.9MFY2024FY2025: $32.4M$32.4MFY2025

From STXS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 16). Last 12 months adds up the four latest quarters.

Last report
Aug 11
2026 · After the close (AMC)
Reported EPS
-$0.05
vs -$0.03 est. · miss
Year-ago EPS
—
Not on file
Options-implied move
±49.7%
Priced in before that report
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated STXS in the past 90 days, not enough for a consensus
Average 12-month target
$2.50
▲ 183.4% upside

Based on 2 analysts who set a price target on STXS in the past 90 days. The average target is $2.50, with a high of $3.00 and a low of $2.00, compared with the last close of $0.88.

Low $2.00Avg $2.50High $3.00
Blue marker: last close $0.88
Highest target$3.00
Average target$2.50
Lowest target$2.00
Latest rating changes
TD CowenTarget lowered
Nov 11Buy$3 → $2
CitizensMaintained
Aug 27Buy$3
TD CowenMaintained
Aug 12Buy$3
Roth CapitalReinstated
Nov 5Buy$4
DateFirmActionRatingPrice target
Nov 11TD CowenTarget loweredBuy$3 → $2
Aug 27CitizensMaintainedBuy$3
Aug 12TD CowenMaintainedBuy$3
Nov 5Roth CapitalReinstatedBuy$4
Loading…

Technical Analysis

STXS · as of the Nov 17 close · updated after every close
Downtrend

The stock is 8% below its 20 day and 26% below its 50 day average. It is 83% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 42). The nearest support is the Pivot at $0.86, and the nearest resistance the Pivot R1 at $0.93.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 10.8%/day
Key levels
$2.8652 week high+225.0%
$1.61200 day average+83.0%
$1.29100 day average+46.6%
$1.1150 day average+26.1%
$1.04Swing high (Oct 23)+18.2%
$0.9520 day average+8.0%
$0.93Pivot R1+5.7%
$0.88Last close
$0.86Pivot−2.3%
$0.82Pivot S1−6.8%
$0.8052 week low−9.1%
$0.80Swing low (Nov 3)−9.1%
Indicators
RSI (14)41.53Middle of its rangeNeutral
MACD-0.06Below its signal lineBearish
Stochastic10.0Near the bottom of its rangeOversold
ADX (14)35.7Trending down
Williams %R-80.7Oversold below −80, overbought above −20Oversold
CCI (20)-78.9Oversold below −100, overbought above 100Neutral
Rate of change+3.9%Change over 10 sessionsBullish
ATR (14)$0.10Typical daily range, 10.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for STXS

What happened before

See how STXS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow STXS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How STXS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in STXS in the last 90 days.

Loading…

See today’s whale options flow across the market →

STXS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ●43 buying vs 48 selling
  • ▼Held by funds -2.1 pts
  • ▼Funds holding -7
  • ▼Superinvestors: 0 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding102109−6.4%
In funds' top 1013−66.7%
Held by funds40.8%42.9%−2.1 pts
New / increased10 / 3313 / 44−24.6%
Reduced / sold out31 / 1722 / 16+26.3%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See STXS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STXS is in one of them and how their past STXS trades turned out.

STXS in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered STXS in an article yet. Here's the latest on the wider market.

About Stereotaxis

Stereotaxis is a medical technology company based in St. Louis, Missouri. It makes electromedical systems and disposable interventional devices that physicians use to perform medical procedures. Its main customers are hospitals and the physicians who practice in them. Its product lines include Niobe, Genesis RMN, and Odyssey, and it works with business partners and seeks regulatory approval for additional disposable devices.

Headquarters
St.Louis, MO